COMET Package: Automated seqIF Stainer and Imaging System for Spatial Multiomics Analysis
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) has issued a Notice of Intent to Sole Source for a COMET Package: Automated seqIF Stainer and Imaging System for Spatial Multiomics Analysis. The NIH intends to award this contract non-competitively to Advanced Cell Diagnostics Inc. for an amount not exceeding the simplified acquisition threshold of $350,000. Interested parties may submit capability statements by June 20, 2026, at 9:00 AM Eastern Time.
Purpose & Scope
This acquisition aims to procure and implement an automated multiplex sequential immunofluorescence (seqIF) stainer and imaging system. This system will support the NHLBI research program by enabling advanced spatial multiomics analysis, providing automated workflows for staining, imaging, and signal removal. It will facilitate the detection of multiple protein and RNA targets within the same tissue section, allowing for high-resolution, spatially resolved analysis of molecular and cellular interactions in studies related to lung biology, transplant injury, immune cell interactions, and disease mechanisms. The goal is to enhance laboratory efficiency, throughput, and reproducibility.
Contract Details
- Type: Presolicitation / Notice of Intent to Sole Source
- NAICS: 334516 (Size Standard: 1,000 employees)
- Acquisition Method: FAR Subpart 13 – Simplified Acquisition Procedures
- Estimated Value: Not exceeding $350,000
- Place of Performance: Bethesda, MD
Set-Aside
This is a non-competitive synopsis with the intent to award to Advanced Cell Diagnostics Inc. There is no set-aside designation for this procurement.
Submission & Evaluation
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond. Responses must include a technical proposal, cost-price proposal, proposed period of performance, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must have an active registration in SAM.gov. The Government's determination not to compete is at its sole discretion, and information received may influence whether to proceed non-competitively or conduct a competitive procurement.
Deadlines & Contact
- Responses Due: June 20, 2026, 9:00 AM Eastern Time
- Submission: Electronically to Michael Falzone, Contracting Officer, at Michael.falzone@nih.gov.